The small intestine shields the liver from fructose-induced steatosis.
The small intestine shields the liver from fructose-induced steatosis.
复制标题
小肠保护肝脏免受果糖引起的脂肪变性。
DOI:
10.1038/s42255-020-0222-9
复制
发表时间:
2020-07
影响因子:
20.8
通讯作者:
Rabinowitz JD
中科院分区:
文献类型:
--
作者:
Jang C;Wada S;Yang S;Gosis B;Zeng X;Zhang Z;Shen Y;Lee G;Arany Z;Rabinowitz JD
Per capita fructose consumption has increased 100-fold over the last century. Epidemiological studies suggest that excessive fructose consumption, and especially consumption of sweet drinks, is associated with hyperlipidaemia, non-alcoholic fatty liver disease, obesity and diabetes. Fructose metabolism begins with its phosphorylation by the enzyme ketohexokinase (KHK), which exists in two alternatively spliced forms. The more active isozyme, KHK-C, is expressed most strongly in the liver, but also substantially in the small intestine where it drives dietary fructose absorption and conversion into other metabolites before fructose reaches the liver. It is unclear whether intestinal fructose metabolism prevents or contributes to fructose-induced lipogenesis and liver pathology. Here we show that intestinal fructose catabolism mitigates fructose-induced hepatic lipogenesis. In mice, intestine-specific KHK-C deletion increases dietary fructose transit to the liver and gut microbiota and sensitizes mice to fructose’s hyperlipidaemic effects and hepatic steatosis. In contrast, intestine-specific KHK-C overexpression promotes intestinal fructose clearance and decreases fructose-induced lipogenesis. Thus, intestinal fructose clearance capacity controls the rate at which fructose can be safely ingested. Consistent with this, we show that the same amount of fructose is more strongly lipogenic when drunk than eaten, or when administered as a single gavage, as opposed to multiple doses spread over 45 min. Collectively, these data demonstrate that fructose induces lipogenesis when its dietary intake rate exceeds the intestinal clearance capacity. In the modern context of ready food availability, the resulting fructose spillover drives metabolic syndrome. Slower fructose intake, tailored to intestinal capacity, can mitigate these consequences.
登录
查看更多内容
影响因子:
29
作者:
Jang C;Hui S;Lu W;Cowan AJ;Morscher RJ;Lee G;Liu W;Tesz GJ;Birnbaum MJ;Rabinowitz JD
通讯作者:
Rabinowitz JD
影响因子:
4.7
作者:
通讯作者:
--
影响因子:
4.3
作者:
Chao CY;Battat R;Al Khoury A;Restellini S;Sebastiani G;Bessissow T
通讯作者:
Bessissow T
影响因子:
15.9
作者:
Lanaspa, Miguel A.;Andres-Hernando, Ana;Tolan, Dean R.
通讯作者:
Tolan, Dean R.
影响因子:
3.6
作者:
DURAN, M;BEEMER, FA;WADMAN, SK
通讯作者:
WADMAN, SK